[Clinical evaluation of SM-4300 against bacterial infections in the field of internal medicine].

Abstract

A new drug of human intact immunoglobulin, SM-4300 was applied to the acute respiratory infections in the field of internal medicine. SM-4300 was administered intravenously for 1 or 3 days at a daily dose of 2.5 g to 4 patients suffering from respiratory infections. We have obtained the results as follows. Clinical effects of SM-4300 were good in 2 cases, fair in 1 case, unknown in 1 case, and no side effects were observed.

• Authors: M Yamakido, S Takami, K Nohmi, K Sadamoto
• Journal: The Japanese journal of antibiotics (Jpn J Antibiot) Vol. 38 Issue 9 Pg. 2532-4 (Sep 1985) ISSN: 0368-2781 [Print] Japan
• PMID: 3866098 (Publication Type: English Abstract, Journal Article)

Chemical References

• Cephamycins
• Immunoglobulins
• SM-4300
• Cefmetazole
• Lincomycin

Topics

• Aged
• Bacteria (immunology)
• Cefmetazole
• Cephamycins (administration & dosage)
• Drug Evaluation
• Drug Resistance, Microbial
• Drug Therapy, Combination
• Female
• Humans
• Immunization, Passive
• Immunoglobulins (administration & dosage)
• Lincomycin (administration & dosage)
• Male
• Middle Aged
• Respiratory Tract Infections (therapy)